The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

Alongside opening the new offices, Roche Diagnostics capabilities in China have been further recognised as it has been ...

These jobs will propel the province towards being a global leader in biomanufacturing and life sciences. MISSISSAUGA, ON, Nov ...

Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...

This not only is a high recognition of Roche Diagnostics' innovative strength but also motivates us to further create sustainable value for patients through a new model and through an 'in China ...

Kazmierczak also appreciates that flexibility. “Roche provides phenomenal work-life balance, with great benefits, making it ...

Wish4Life Foundation, a US-based non-government organisation (NGO) dedicated to the care of children battling with cancer, is ...

Tests for pre-eclampsia, which affects around 5,000 pregnancies each year, has been brought in by NHS Lothian.